How to write a better marketing plan - 10 steps to success - Dr Patrick Dixon for Post Danmak

How to develop a better marketing plan - presentation slides and videos

Future of Interactive Marketing - Dr Patrick Dixon for Skynet Belgacom

Interactive Marketing - Direct marketing in a digital world: iDTV, PDAs, SMS, mobile marketing, viral marketing, video marketing, opt-in e-mail campaigns - Keynote event for Skynet Belgacom high-level client marketing event. Low cost, high impact advertising campaigns - why interactive marketing is set to grow rapidly. Key marketing success stories and dangers to avoid.

Innovation - unleash the power! Dr Patrick Dixon workshop

Innovate!: Great Ideas for Radical Business Success - Innovation is fundamental to ongoing business health and product development. Macro-innovation and micro-innovation and why you need both. How to generate low cost, practical ideas that you can implement tomorrow at almost zero cost, with immediate support from management and rapid payback. Use the same process to find major innovations to transform your entire business..

Future of BBC radio, TV, online, broadcasting, audiences, social trends, news, current affairs, charter review - and commercial television - by Dr Patrick Dixon


Future of the BBC - public service broadcasting trends - UK TV, radio and world service - charter review. Presentation to 100 of most senior BBC executives. Sensitive client information has been deleted from this presentation. See also Future of BBC News Services - BBC World TV News, Global News and BBC World Service News. Presentation for senior news editors / executives.

Strategic Planning and Future of Business Strategy

Business school executive programme presentation. You can have the best strategy in the world, the best change management methods and the most talented teams but if your view of the future is wrong you will just go even faster in the wrong direction. We need future-vision, to be futurewise, and to understand what the prime drivers of strategic transformation will be for the next decade. A single four-word phrase will be the basis of all strategic transformation, all marketing and mission statements and all successful leadership...

UNIDO - impact of accession to EU of Central and Eastern Europen nations - and technology issues

The Future of Europe - keynote speech for UNIDO looking at the impact of joining the EU for 10 accession countries, and also the effect of new technology on their economies. Audience: cabinet ministers of 7 nations, and other government leaders from another six, including the Deputy Prime Minister of Ireland.

Futurewise - Dr Patrick Dixon

Futurewise CEO Summit - keynote address at Unisys client event for CEOs of some of Europe's largest corporations including Banque de France, on global trends, the future of Europe, changes in consumer behaviour, investor expectations and corporate ethics (Grand Prix / Monaco - co-themed multimedia presentation).

Global Change Ltd - website statistics

Huge growth in traffic to our site - 7 million unique visitors
1 in 40 of all US web users have visited these pages since 1996.
1 in 440 Americans searching the web in a busy month comes here for answers. Around 60 million words requested in a single 24 hour period by 18,000 individual visitors who spent over 2,000 hours on site. Pages authored by Dr Patrick Dixon - in up to four countries a week. More than 15,000 other sites are talking about Dr Dixon.

The Truth About Westminster: "Democracy in Britain is in a dangerous state. Faith in politicians has sunk to an all-time low. But is the public image fair? Cash for questions, lobbying, political favours, patronage, party funding, whipping, indiscretions, secrecy, half-truths...What lies behind these issues?
'In a dictatorship I would have been bumped off - I knew too much. Instead I was sacked.' - Ex-Minister
'Some people can be bought off with an MBE. Others with a knighthood.' - Former Party Agent
'The life of MPs is liable to place them in the path of great sexual temptation.' - Lord Healey
'I sometimes wonder if we can afford the luxury of adversarial politics.' - Lord Weatherill
'We have reached the stage when every man and woman in this House is an object of suspicion.' - Sir Edward Heath
'We cannot legislate for integrity.' - Betty Boothrod
'We must be active in the political arena.' - Clive Calver

Patrick Dixon takes us behind the headlines to give a measured view, based on a series of revealing interviews backed by detailed research. He finds man MPs and Peers struggling with great pressures, conflicts and moral dilemmas. He concludes that the system itself is corrupting, and he proposes comprehensive reforms. He believes men and women with integrity have a vital role to play. "

Acet International Network - ASSET - Christian response to AIDS - Church AIDS programmes: "ACET International Alliance members have:
* Given practical support to more than 3,500 people with AIDS
* Supported over 1,000 orphans
* Educated more than a million children in school lessons about sexual health and drug abuse
* Distributed 1.4 million educational resources to teenagers
* Provided 60,000 free books to workers in hard-hit nations
* Given access for a million free online book chapters
* Educated more than 100,000 health care professionals
* Provided technical support and advice to a large number of national and international agencies based in more than twenty nations, mostly in the poorest parts of the world
In addition, more than a million book chapters and AIDS resources have been downloaded from our website / resource area in the last 18 months.
ACET projects in many nations
ACET Member organisations are found in Uganda, Burundi, Zimbabwe, Thailand, India, Russia, Czech Republic, Slovakia, Slovenia, Ukraine, Croatia, England, Scotland, Ireland, Jersey, Barbados and Guyana with a new Nigeria partnership about to begin. Work is growing most strongly in countries with low national income and high HIV incidence. "

Future of Banking: Video / Features on Future of Financial services, technology, customer relations, retail banking, corporate, wholesale and private banking trends: "Future of banking and financial services in Europe? Rapid European consolidation - Huge reduction in bank branches - Huge growth in online financial services activity - Struggle to be key global finance players - Giants will partner with small players to develop new retail and wholesale financial products and services rapidly - Relationship and trust will always dominate top-end premium banking relationships - One-click bank account changes will be on the horizon - Credit / charge card use will grow as written cheques all but disappear. "

Real Success - Future values, marketing, leadership, motivation and and corporate governance- Dr Patrick Dixon

The Future of Electronic Directories and Databases - EADP - Dr Patrick Dixon

More on Future of Stem Cells - 30,000 page site on future / 45 videos

Future of Stem Cells: Exciting Progress

Embryonic stem cells and adult stem cells - biotech company progress, stem cell investment, stem cell research results, should you invest in stem cell technology, stem cell organ repair and organ regeneration?

Every week there are new claims being made about embryonic stem cells and adult stem cells, what is the truth? Here is a brief summary of important stem cell trends. You will also find on this site keynote presentations on stem cell research, speeches and powerpoint slides on the future of health care, the future of medicine, the future of the pharmaceutical industry, and the future of ageing - all of which are profoundly impacted by stem cell research.

There is no doubt that we are on the edge of a major stem cell breakthrough. Stem cells will one day provide effective low-cost treatment for diabetes, some forms of blindness, heart attack, stroke, spinal cord damage and many other health problems. Animal stem cell studies are already very promising and some clinical trials using stem cells have started (article written in September 2004).

As a physician and a futurist I have been monitoring the future of stem cells for over two decades, and advise corporations on these issues. Stem cell investment, research effort, and treatment focus is moving rapidly away from embryonic stem cells (ethical and technical challenges) to adult stem cells which are turning out to be far easier to convert into different tissues than we thought in 2000-2003.

I have met a number of leading researchers, and their progress in stem cell research is now astonishing, while over 2,000 new research papers on embryonic or adult stem cells are published in reputable scientific journals every year.

More on Future of Stem Cells - 30,000 page site on future / 45 videos

Stem cell technology is developing so fast that many stem cell scientists are unaware of important progress by others in their own or closely related fields. They are unable to keep up. The most interesting work is often unpublished, or waiting to be published. There is also of course commercial and reputational rivalry, which can on occaisions tempt scientists to downplay the significance of other people's results (or their claims)..

What exactly are stem cells? Will stem cells deliver? Should you invest in biotech companies that are developing stem cell technology? What should physicians, health care professionals, planners and health departments expect? What will be the impact of stem cell treatments on the pharmaceutical industry? How expensive will stem cell treatments be? What about the ban on embryonic stem cell research in many nations? Do embryonic stem cell treatments have a future or will they be overtaken by adult stem cell technology?

What are stem cells - embryonic and adult stem cells

Stem cells are relatively primitive cells that have the ability to divide rapidly to produce more specialized cells. Stem cells in the embryo are capable of huge variation in the kinds of tissues they make, reproduce rapidly and have attracted interest of researchers for decades. However embryonic stem cells are hard to get hold of in humans - you need a supply of human embryos, which requires either breaking the law in some countries or applying for complex licenses in others.

Embryonic stem cells are also hard to control, and hard to grow in a reliable way. They have "minds" of their own, and embryonic stem cells are often unstable, producing unexpected results as they divide, or even cancerous growths. Human embryonic stem cells usually cause an immune reaction when transplanted into people, which means cells used in treatment may be rapidly destroyed unless they are protected, perhaps by giving medication to suppress the immune system (which carries risks).

One reason for intense interest in human cloning technology is so-called therapeutic cloning. This involves combining an adult human cell with a human egg from which the nucleus has been removed. The result is a human embryo which is dividing rapidly to try and become an identical twin of the cloned adult. If implanted in the womb, such cloned embryos have the potential to be born normally as cloned babies, although there are many problems to overcome, including catastrophic malformations and premature ageing as seen in animals such as Dolly the sheep.

In theory, therapeutic cloning could allow scientists to take embryonic stem cells from the cloned embryo, throw the rest of the embryo away and use the stem cells to generate new tissue which is genetically identical to the person cloned. In practice this is a very expensive approach fraught with technical challenges as well as ethical questions and legal challenges.

An alternative is to try to create a vast tissue bank of tens of thousands of embryonic cells lines, by extracting stem cells from so many different human embryos that whoever needs treatment can be closely matched with the tissue type of an existing cell line. But even if this is achieved, problems of control and cancer remain. And again there are many ethical considerations with any science that uses human embryos, each of which is an early developing but complete potential human being, which is why so many countries have banned this work.

The alternative to using embryonic stem cells

Until recently it was taught in all medical schools that cells in the embryo were multipotent - able to give rise to every tissue - but by birth, this capacity was permanently lost. That has been the reason why almost all research effort focused on embryonic stem cells until just a few years ago.

However a moment's thought tells us how illogical such a view was, and indeed we are now finding that many cells in children and adults have extraordinary capacity to generate or stimulate growth of a wide variety of tissues, if encouraged in the right way.

More on Future of Stem Cells - 30,000 page site on future / 45 videos

Take for example the work of Professor Jonathan Slack at Bath University who has shown how adult human liver cells can be transformed relatively easily into insulin producing cells such as those found in the pancreas, or the work of others using bone marrow cells to repair brain and spinal cord injuries in mice and rats, and now doing the same to repair heart muscle in humans.

Why should this surprise us? We know that almost all cells in your body contain your entire genome or book of life: enough information to make an entire copy of you, which is the basis of cloning technology. So in theory just about every cell can make any tissue you need. However the reality is that in most cells almost every gene you have is turned off - but as it turns out, not as permanently as we thought.

If we take one of your skin cells and fuse it with an unfertilized human egg, the chemical bath inside a human egg activates all the silenced genes, and the combined cell becomes so totipotent that it starts to make a new human being.

What then if we could find a way to reactivate just a few silenced genes, and perhaps at the same time silence some of the others? Could we find a chemical that would mimic what happens in the embryo, with the power to transform cells from one type into another? Yes we can. Jonathan Slack and others have done just that. What was considered impossible five years ago is already history.

Could we take adult cells and force them back into a more general, undetermined embryonic state? Yes we can. It is now possible to create cells with a wide range of plasticity, all from adult tissue. The secret is to get the right gene activators into the nucleus, not so hard as we thought.

Impact of embryonic and adult stem cells on the future of medicine and health care

Stem cell therapy is not a conventional treatment using an external agent and so the normal 15 year development pipeline for new pharmaceutical products does not apply. Indeed the gap between seeing promising stem cell results in animals and starting first human trials can be as short as 15 days.

Suppose you have a heart attack. A cardiothoracic surgeon talks to you about using your own stem cells in an experimental treatment. You agree. A sample of bone marrow is taken from your hips, and processed using standard equipment found in most oncology centers for treating leukemia. The result is a concentrated number of special bone marrow cells, which are then injected back into your own body - either into a vein in your arm, or perhaps direct into the heart itself.

The surgeon is returning your own unaltered stem cells back to you, to whom these cells legally belong. This is not a new molecule requiring years of animal and clinical tests. Your own adult stem cells are available right now. No factory is involved - nor any pharmaceutical company sales team.

What is more, there are no ethical questions (unlike embryonic stem cells), no risk of tissue rejection, no risk of cancer.

Now we begin to see why research funds are moving so fast from embryonic stem cells to adult alternatives.

Harvard Medical School is another center of astonishing progress in adult stem cells. Trials have shown partially restored sight in animals with retinal damage. Clinical trials are expected within five years, using adult stem cells as a treatment to cure blindness caused by macular degeneration - old-age blindness and the commonest cause of sight-loss in America. Within 10 years it is hoped that people will be able to be treated routinely with their own stem cells in a clinic using a two-hour process.

If you want further evidence of this switch in interest from embryonic to adult stem cells,, look at the makers of Dolly the sheep. The Rosslyn Institute in Scotland are pioneers in cloning technology. They along with others campaigned successfully in UK Parliament for the legal right to use the same technology in human embryos (therapeutic cloning, not with the aim of clones being born). But three years later, they had not even bothered to apply for a human cloning licence.

Why not? Because investors were worried about throwing money at speculative embryo research with massive ethical and reputational risks. Newcastle University made headlines in August 2004 when granted the first licence to clone human embryos - but the real story was why it had taken so long to get a single research institute in the UK to actually get on and apply. Answer: medical research moved on and left the "therapeutic" human cloners behind.

Do stem cells really repair tissue?

For several years there has been a curious and very confusing debate in editorials of publications like the New England Journal of Medicine about whether adult stem cells actually regenerate tissue or not.

More on Future of Stem Cells - 30,000 page site on future / 45 videos

The debate centers on technical questions and semantics, rather than the reality of results. Take for example heart repair. We know that bone marrow cells can land up in damaged heart and when present, the heart is repaired. It is hard to be certain what proportion of this remarkable process is due to stimulants released locally by bone marrow cells, or by the bone marrow cells actually differentiating into heart tissue.

It remains a confusing picture, not least because in the lab, cells seem to change character profoundly, but in clinical trials it appears the effects of many stem cells are stimulatory. But who cares? As a clinician I am delighted if injecting your bone marrow cells into your back means that you are walking around 3 months after a terrible injury to your spine instead of being in a wheelchair for the rest of your life. I am not so concerned with exactly how it all works, and nor will you be.

The future of stem cells

In summary, expect rapid progress in adult stem cells and slower, less intense work with embryonic stem cells. Embryonic stem cell technology is already looking rather last-century, along with therapeutic cloning. History will show that by 2020 we were already able to produce a wide range of tissues using adult stem cells, with spectacular progress in tissue building and repair. In some cases these stem cells will be actually incorporated into the new repairs as differentiated cells, in other cases, they will be temporary assistants in local repair processes.

We will also see some exciting new pharmaceutical products in the pipeline, which promise to do some of the same tricks without having to remove a single stem cell from the body. These drugs may for example activate bone marrow cells and encourage them to migrate to parts of the body where repairs are needed.

And along the way we will see a number of biotech companies fold, as a result of over-investment into embryonic stem cells, plus angst over ethics and image, without watching the radar screen closely enough, failing to see the onward march of adult stem cell technology.

Using embryos as a source of spare-part cells will always be far more controversial than using adult tissue, or perhaps cells from umbilical cord after birth, and investors will wish to reduce uneccessary risk, both to the projects they fund, and to their own organisations by association.

Despite this, we can expect embryonic stem cell research to continue in some countries, with the hope of scientific breakthroughs of various kinds.

More on Future of Stem Cells - 30,000 page site on future / 45 videos

Acet International Home

Just returned from week in India - Calcutta, Mumbai and Goa - 2nd visit in 4 months - visiting a number of projects connected with ACET International Alliance and Oasis. Very moving and also shocking at times, yet so much can be done to save lives and give people care as well as hope, even in the most desparate situations of extreme poverty and vunerability, street projects, slum projects, girls sold as sex industry slaves and so on.